人乳头瘤病毒核酸分型检测试剂盒(荧光PCR法)Abbott RealTime High Risk HPV,人乳头瘤病毒核酸分型检测扩增试剂盒:扩增试剂包;人乳头瘤病毒核酸分型检测对照试剂盒:阴性对照、阳性对照。(具体内容详见说明书),人乳头瘤病毒核酸分型检测试剂盒(荧光PCR法)Abbott RealTi
2009. Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology. J. Clin. Virol. 45(Suppl. 1):S19-S23.Huang, S., B. Erickson, N. Tang, W. B. Mak, J. Salituro, J. Robinson, and K. Abr...
INTRODUCTION: (HPV) testing has become an essential part of current clinical practice in the management of and . We reviewed the most important validation studies of a next-generation real-time polymerase chain reaction-based assay, the RealTime High Risk HPV test (RealTime)(Abbott Molecular, De...
Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. J. Virol. Methods 175, 117-119.Kocjan BJ, Seme K, Poljak M. Comparison of the Abbott Real...
However, screening with human papillomavirus (HPV) molecular tests holds promise for reducing cervical cancer incidence and mortality in low- and middle-income countries. The performance of the Abbott RealTime High-Risk HPV test (AbRT) was evaluated in 83 cervical smear specimens and compared with ...
PX-8 Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting 来自 Elsevier 喜欢 0 阅读量: 22 作者: S. Venturoli and E. Leo and M. Cricca and M. Nocera and M. Plazzi and M. Musiani and M. ...
Knowing which genotype of HPV is causing an infection is critical to assessing the likelihood of the infection leading to cancer, and there are 14 HPV genotypes that are classified as high risk (HR) based on their carcinogenic potential. Unfortunately, not all HR HPV...
Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting. Randomized trials have produced sound evidence about the efficacy of screening with human papillomavirus (HPV) DNA tests in reducing cervical cancer incide... FM Car...
Comparison of the Abbott RealTime high risk HPV with Genomica HPV clinical Array for the detection of human papillomavirus DNA. APMIS. 2013;121:1054-63. https://doi.org/10.1111/apm.12054.Comparison of the Abbott RealTime High Risk HPV with Genomica HPV Clinical Array for the detection of ...
Capobianchi, Comparison of the Abbott RealTime high risk HPV with genomica HPV clinical array for the detection of human papillomavirus DNA, APMIS 121 (11) (2013) 1054-1063.Comparison of the Abbott RealTime High Risk HPV with Genomica HPV Clinical Array for the detection of human papillomavirus...